drugset / Trial / NCT01860573

Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants

NCT01860573

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.

Timeline

Start
2008-11
Primary completion
2013-03
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject amino acids Unknown 4 g/kg

Indications

No indication recorded.